Attention | The TGA’s Planned Cosmetic Injectable Mailout

The Therapeutic Goods Administration (TGA) is about to commence the first round of a mail-out regarding concerns related to the advertising of cosmetic injectables. The rapid advancement of technology and the increase in sophisticated, data-driven advertising campaigns has resulted in a significant volume of non-compliant advertisements. To address this increase, the Regulatory Compliance Branch (RCB) within the TGA has formed a new Targeted Compliance Unit (TCU).

This TCU will concentrate on monitoring and addressing non-compliant advertising, by focusing on identified non-compliance outside their published compliance priorities.

To ensure compliance, the team will soon launch a targeted letter campaign addressing non-compliant advertising of cosmetic injectables. Each reported entity and individual will receive:
• Guidance Letter: Informing and guiding on how to be compliant with advertising rules, referencing relevant legislation, best practices, and guidance. Encouraging voluntary review and removal of non-compliant advertising.
• Top 10 Fact Sheet: Information on the most common questions asked by advertisers.

The recipients will be given four weeks to adjust their advertising, during which the TCU will monitor for behavioural changes. Those who consistently or deliberately exhibit severe misconduct will undergo assessment for potential compliance or enforcement actions.

Please click on the documents below for further information:
• Overview of the TGA’s planned cosmetic injectable mailout
• Top 10 Fact Sheet